H2 receptor antagonist treatment and stomach cancer
Amland, P.F.; Svane, S.
Tidsskrift for den Norske Laegeforening Tidsskrift for Praktisk Medicin Ny Raekke 107(12): 1023
1987
ISSN/ISBN: 0029-2001 PMID: 2885944 Document Number: 291149
Document emailed within 1 workday
Related Documents
Overgaard, H.; Timshel, S. 1996: Late recurrence of stomach cancer in a patient treated with a H2 receptor antagonist Ugeskrift for Laeger 158(19): 2717-2718Buzdar, A.U. 2004: Fulvestrant: a new type of estrogen receptor antagonist for the treatment of advanced breast cancer Drugs of Today 40(9): 751-764
Gabay, C.; Porter, B.; Fantuzzi, G.; Arend, W.P. 1998: Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo Journal of Immunology 159(12): 5905-5913
Cabral, J.E.; Pontes, J.M.; Toste, M.; Camacho, E.; Leitão, M.C.; Freitas, D.; Monteiro, J.G. 1991: Watermelon stomach: treatment with a serotonin antagonist American Journal of Gastroenterology 86(7): 927-928
Sehouli, J.; Mustea, A.; Könsgen, D.; Katsares, I.; Lichtenegger, W. 2002: Polymorphism of IL-1 receptor antagonist gene: role in cancer Anticancer Research 22(6a): 3421-3424
Ennis, C.; Cox, B. 1980: The dopamine receptor antagonist domperidone is also a competitive antagonist at alpha 1-adrenoceptors Journal of Pharmacy and Pharmacology 32(6): 434-435
Wyllie, J.H. 1978: Histamine H2-receptor antagonist in treatment of peptic ulcer Postgraduate Medicine 63(4): 91
Orihuela, P.A. 2007: Ulipristal, a progesterone receptor antagonist as a contraceptive and for the treatment of uterine fibroids Current Opinion in Investigational Drugs 8(10): 859-866
Boermeester, M.A.; van Leeuwen, P.A.; Schneider, A.J.; Houdijk, A.P.; Ferwerda, C.C.; Wesdorp, R.I. 1993: Interleukin-1 receptor antagonist: a new therapeutic agent in the treatment of sepsis syndrome Nederlands Tijdschrift Voor Geneeskunde 137(7): 337-342
Noie, T.; Harihara, Y.; Konishi, T. 2012: II. Stomach 2. Community networks for treatment of stomach cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(9): 1350-1355
Taguchi, K.; Iihara, H.; Ishihara, M.; Komori, Y.; Tanizawa, K.; Matsuura, K.; Itoh, Y. 2009: Comparison of antiemetic efficacy between single and repeated treatments with a 5-HT3 receptor antagonist in breast cancer patients with high-risk emetogenic chemotherapy Anticancer Research 29(5): 1721-1725
Böttcher, K.; Siewert, J.R.; Roder, J.D.; Busch, R.; Hermanek, P.; Meyer, H.J. 1994: Risk of surgical therapy of stomach cancer in Germany. Results of the German 1992 Stomach Cancer Study. German Stomach Cancer Study Group ('92) Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 65(4): 298-306
Hayashi, H.; Onozaki, K. 2010: Interleukin-1(IL-1) alpha, beta, IL-1 receptor (IL-1R), IL-1 receptor antagonist (IL-1ra) Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 7): 62-66
Hayashi, H.; Onozaki, K. 2005: Interleukin-1 (IL-1) alpha, beta, IL-1 receptor, IL-1 receptor antagonist (IL-1ra) Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 8): 60-64
Skuza, G. 2000: Combined treatment with NMDA antagonist, CGP 37849, and sigma receptor agonists, SA4503 or DTG, decreases the neuroleptic-induced catalepsy in rats Polish Journal of Pharmacology 52(4): 313-316
Habu, Y.; Yoshino, T.; Shio, S.; Hayakumo, T.; Kawai, K. 2004: Evaluation of the efficacy and the cost-effectiveness of maintenance treatment of gastroesophageal reflux disease: proton pump inhibitor versus histamine-2-receptor antagonist Nihon Rinsho. Japanese Journal of Clinical Medicine 62(8): 1504-1509
Yang, W.; Chen, J.; Li, W.; Chen, X. 2008: Preventive effects of 4 Se-enriched plants on rat stomach cancer induced by MNNG 2. Safety of different selenium resources for prevention of stomach cancer Wei Sheng Yan Jiu 37(1): 90-92
Spetea, M.; Asim, M.Faheem.; Noha, S.; Wolber, G.; Schmidhammer, H. 2013: Current κ opioid receptor ligands and discovery of a new molecular scaffold as a κ opioid receptor antagonist using pharmacophore-based virtual screening Current Pharmaceutical Design 19(42): 7362-7372
Hwang, S.B.; Lam, M.H.; Hsu, A.H. 1989: Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors Molecular Pharmacology 35(1): 48-58
Berner, B.D.; Conner, C.S.; Sawyer, D.R.; Siepler, J.K. 1983: Ranitidine: a new H2-receptor antagonist Clinical Pharmacy 1(6): 499-509